Evaluation of the osteoinductive potential of a bio-inspired scaffold mimicking the osteogenic niche for bone augmentation

Biomaterials

Volumn 62, Issue , 2015, Pages 128-137

  Minardi, Silvia ^a,b   Corradetti, Bruna ^b,c   Taraballi, Francesca ^b   Sandri, Monica ^a   Van Eps, Jeffrey ^b,d   Cabrera, Fernando J ^b   Weiner, Bradley K ^b,d   Tampieri, Anna ^a   Tasciotti, Ennio ^b  

^a INSTITUTE OF SCIENCE AND TECHNOLOGY FOR CERAMICS   (Italy)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^d HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

Biomimetic material; Biomineralization; Bone regeneration; Hydroxyapatite; Stem cells

Indexed keywords

BIOMECHANICS; BIOMIMETIC MATERIALS; BIOMIMETICS; BIOMINERALIZATION; BONE; CELL CULTURE; GENE EXPRESSION; HYDROXYAPATITE; NANOSTRUCTURES; STEM CELLS; TISSUE REGENERATION;

BIOLOGICALLY INSPIRED; BONE REGENERATION; HUMAN BONE MARROW DERIVED MESENCHYMAL STEM CELLS; HUMAN TRABECULAR BONE; MINERALIZATION PROCESS; NANOMECHANICAL PROPERTY; OSTEOGENIC DIFFERENTIATION; OSTEOINDUCTIVE POTENTIAL;

SCAFFOLDS (BIOLOGY);

APATITE; COLLAGEN TYPE 1; HYDROXYAPATITE; MAGNESIUM DERIVATIVE; MOLECULAR SCAFFOLD; NANOCRYSTAL; BONE PROSTHESIS;

ANIMAL EXPERIMENT; ARTICLE; ATOMIC EMISSION SPECTROMETRY; BONE AUGMENTATION; BONE DEVELOPMENT; BONE MINERALIZATION; BONE REGENERATION; CELL ADHESION; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CELLULAR DISTRIBUTION; CHEMICAL COMPOSITION; CHEMICAL INTERACTION; COMPARATIVE STUDY; CONTROLLED STUDY; CORTICAL BONE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IN VITRO STUDY; INFRARED SPECTROSCOPY; MESENCHYMAL STEM CELL; MOLECULAR MECHANICS; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; RABBIT; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; THERMOGRAVIMETRY; TRABECULAR BONE; X RAY DIFFRACTION; ANIMAL; BIOMIMETICS; BONE PROSTHESIS; CELL CULTURE; CYTOLOGY; DEVICE FAILURE ANALYSIS; DEVICES; EQUIPMENT DESIGN; EVALUATION STUDY; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; OSTEOBLAST; PHYSIOLOGY; STEM CELL NICHE; SYNTHESIS; TISSUE SCAFFOLD;

ORYCTOLAGUS CUNICULUS;

ANIMALS; BIOMIMETICS; BONE REGENERATION; BONE SUBSTITUTES; CELL DIFFERENTIATION; CELLS, CULTURED; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; OSTEOBLASTS; OSTEOGENESIS; RABBITS; STEM CELL NICHE; TISSUE SCAFFOLDS;

EID: 84930789350     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.05.011     Document Type: Article

References (64)

1. McAllister B.S., Haghighat K. Bone augmentation techniques. J. Periodontol. 2007, 78:377-396.
2. Chiapasco M., Casentini P., Zaniboni M. Bone augmentation procedures in implant dentistry. Int. J. oral Maxillofac. implants 2008, 24:237-259.
3. Hak D.J. The use of osteoconductive bone graft substitutes in orthopaedic trauma. J. Am. Acad. Orthop. Surg. 2007, 15:525-536.
4. Arrington E.D., Smith W.J., Chambers H.G., Bucknell A.L., Davino N.A. Complications of iliac crest bone graft harvesting. Clin. Orthop. Relat. Res. 1996, 329:300-309.
5. Bucholz R.W. Nonallograft osteoconductive bone graft substitutes. Clin. Orthop. Relat. Res. 2002, 395:44-52.
6. Silber J.S., Anderson D.G., Daffner S.D., Brislin B.T., Leland J.M., Hilibrand A.S., et al. Donor site morbidity after anterior iliac crest bone harvest for single-level anterior cervical discectomy and fusion. Spine 2003, 28:134-139.
7. Giannoudis P.V., Dinopoulos H., Tsiridis E. Bone substitutes: an update. Injury 2005, 36:S20-S27.
8. Zimmermann G., Moghaddam A. Allograft bone matrix versus synthetic bone graft substitutes. Injury 2011, 42:S16-S21.
9. Khan Y., Yaszemski M.J., Mikos A.G., Laurencin C.T. Tissue engineering of bone: material and matrix considerations. J. Bone Jt. Surg. 2008, 90:36-42.
10. Greenwald A.S., Boden S.D., Goldberg V.M., Khan Y., Laurencin C.T., Rosier R.N. Bone-graft substitutes: facts, fictions, and applications. J. Bone Jt. Surg. 2001, 83:S98-S103.
11. Nair L.S., Laurencin C.T. Biodegradable polymers as biomaterials. Prog. Polym. Sci. 2007, 32:762-798.
12. Kellomäki M., Niiranen H., Puumanen K., Ashammakhi N., Waris T., Törmälä P. Bioabsorbable scaffolds for guided bone regeneration and generation. Biomaterials 2000, 21:2495-2505.
13. Hutmacher D.W. Scaffolds in tissue engineering bone and cartilage. Biomaterials 2000, 21:2529-2543.
14. Kempen D.H., Lu L., Heijink A., Hefferan T.E., Creemers L.B., Maran A., et al. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials 2009, 30:2816-2825.
15. Yilgor P., Tuzlakoglu K., Reis R.L., Hasirci N., Hasirci V. Incorporation of a sequential BMP-2/BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering. Biomaterials 2009, 30:3551-3559.
16. Manassero M., Viateau V., Deschepper M., Oudina K., Logeart-Avramoglou D., Petite H., et al. Bone regeneration in sheep using acropora coral, a natural resorbable scaffold, and autologous mesenchymal stem cells. Tissue Eng. Part A 2013, 19:1554-1563.
17. Bose S., Roy M., Bandyopadhyay A. Recent advances in bone tissue engineering scaffolds. Trends Biotechnol. 2012, 30:546-554.
18. Biondi M., Ungaro F., Quaglia F., Netti P.A. Controlled drug delivery in tissue engineering. Adv. Drug Deliv. Rev. 2008, 60:229-242.
19. Carragee E.J., Hurwitz E.L., Weiner B.K. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J. 2011, 11:471-491.
20. Minardi S., Sandri M., Martinez J.O., Yazdi I.K., Liu X., Ferrari M., et al. Multiscale patterning of a biomimetic scaffold integrated with composite microspheres. Small 2014, 10(19):3943-3953.
21. Epstein N.E. Complications due to the use of BMP/INFUSE in spine surgery: the evidence continues to mount. Surg. Neurol. Int. 2013, 4:S343.
22. Fu R., Selph S., McDonagh M., Peterson K., Tiwari A., Chou R., et al. Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion: a systematic review and meta-analysis. Ann. Intern. Med. 2013, 158:890-902.
23. Patterson J., Martino M.M., Hubbell J.A. Biomimetic materials in tissue engineering. Mater. Today 2010, 13:14-22.
24. Bose S., Tarafder S. Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: a review. Acta Biomater. 2012, 8:1401-1421.
25. Wagoner Johnson A.J., Herschler B.A. A review of the mechanical behavior of CaP and CaP/polymer composites for applications in bone replacement and repair. Acta Biomater. 2011, 7:16-30.
26. Raisz L.G. Physiology and pathophysiology of bone remodeling. Clin. Chem. 1999, 45:1353-1358.
27. Katz E.P., Li S.-T. Structure and function of bone collagen fibrils. J. Mol. Biol. 1973, 80:1-15.
28. De Bruijn J., Klein C., De Groot K., Van Blitterswijk C. The ultrastructure of the bone-hydroxyapatite interface in vitro. J. Biomed. Mater. Res. 1992, 26:1365-1382.
29. Bertinetti L., Drouet C., Combes C., Rey C., Tampieri A., Coluccia S., et al. Surface characteristics of nanocrystalline apatites: effect of Mg surface enrichment on morphology, surface hydration species, and cationic environments. Langmuir 2009, 25:5647-5654.
30. Landi E., Logroscino G., Proietti L., Tampieri A., Sandri M., Sprio S. Biomimetic Mg-substituted hydroxyapatite: from synthesis to in vivo behaviour. J. Mater. Sci. Mater. Med. 2008, 19:239-247.
31. Kheir E., Stapleton T., Shaw D., Jin Z., Fisher J., Ingham E. Development and characterization of an acellular porcine cartilage bone matrix for use in tissue engineering. J. Biomed. Mater. Res. Part A 2011, 99:283-294.
32. Taraballi F., Wang S., Li J., Lee F.Y.Y., Venkatraman S.S., Birch W.R., et al. Understanding the nano-topography changes and cellular influences resulting from the surface adsorption of human hair keratins. Adv. Healthc. Mater. 2012, 1:513-519.
33. Liu Y., Luo D., Kou X.-X., Wang X.-D., Tay F.R., Sha Y.-L., et al. Hierarchical intrafibrillar nanocarbonated apatite assembly improves the nanomechanics and cytocompatibility of mineralized collagen. Adv. Funct. Mater. 2013, 23:1404-1411.
34. Tampieri A., Sprio S., Sandri M., Valentini F. Mimicking natural bio-mineralization processes: a new tool for osteochondral scaffold development. Trends Biotechnol. 2011, 29:526-535.
35. Mann S. Biomineralization 2001, Oxford University Press, Oxford.
36. Nudelman F., Pieterse K., George A., Bomans P.H., Friedrich H., Brylka L.J., et al. The role of collagen in bone apatite formation in the presence of hydroxyapatite nucleation inhibitors. Nat. Mater. 2010, 9:1004-1009.
37. Sprio S.S.M., Panseri S., Iafisco M., Ruffini A., Minardi S., Tampieri A. Bone substitutes based on biomineralization. Bone Substitutes Biomaterials 2014, Woodhead Publishing.
38. Sprio S., Tampieri A., Landi E., Sandri M., Martorana S., Celotti G., et al. Physico-chemical properties and solubility behaviour of multi-substituted hydroxyapatite powders containing silicon. Mater. Sci. Eng. C 2008, 28:179-187.
39. Landi E., Celotti G., Logroscino G., Tampieri A. Carbonated hydroxyapatite as bone substitute. J. Eur. Ceram. Soc. 2003, 23:2931-2937.
40. Liou S.-C., Chen S.-Y., Lee H.-Y., Bow J.-S. Structural characterization of nano-sized calcium deficient apatite powders. Biomaterials 2004, 25:189-196.
41. Gelain F., Silva D., Caprini A., Taraballi F., Natalello A., Villa O., et al. BMHP1-derived self-assembling peptides: hierarchically assembled structures with self-healing propensity and potential for tissue engineering applications. ACS Nano 2011, 5:1845-1859.
42. Hattner R., Epker B.N., Frost H.M. Suggested sequential mode of control of changes in cell behaviour in adult bone remodelling. Nature 1965, 206:489-490.
43. Takayanagi H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat. Rev. Immunol. 2007, 7:292-304.
44. Corradetti B., Taraballi F., Powell S., Sung D., Minardi S., Ferrari M., et al. Osteoprogenitor cells from bone marrow and cortical bone: understanding how the environment affects their fate. Stem Cells Dev. 2014, 24(9):1112-1123.
45. Zhu H., Guo Z.K., Jiang X.X., Li H., Wang X.Y., Yao H.Y., et al. A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone. Nat. Protoc. 2010, 5:550-560.
46. Sakaguchi Y., Sekiya I., Yagishita K., Ichinose S., Shinomiya K., Muneta T. Suspended cells from trabecular bone by collagenase digestion become virtually identical to mesenchymal stem cells obtained from marrow aspirates. Blood 2004, 104:2728-2735.
47. Sottile V., Halleux C., Bassilana F., Keller H., Seuwen K. Stem cell characteristics of human trabecular bone-derived cells. Bone 2002, 30:699-704.
48. Tuli R., Tuli S., Nandi S., Wang M.L., Alexander P.G., Haleem-Smith H., et al. Characterization of multipotential mesenchymal progenitor cells derived from human trabecular bone. Stem Cells 2003, 21:681-693.
49. Honczarenko M., Le Y., Swierkowski M., Ghiran I., Glodek A.M., Silberstein L.E. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells 2006, 24:1030-1041.
50. Krampera M., Cosmi L., Angeli R., Pasini A., Liotta F., Andreini A., et al. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 2006, 24:386-398.
51. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
52. Friedenstein A.J., Gorskaja J.F., Kulagina N.N. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp. Hematol. 1976, 4:267-274.
53. Yin T., Li L. The stem cell niches in bone. J. Clin. Invest 2006, 116:1195-1201.
54. Schmid G.J., Kobayashi C., Sandell L.J., Ornitz D.M. Fibroblast growth factor expression during skeletal fracture healing in mice. Dev. Dyn. 2009, 238:766-774.
55. Sarahrudi K., Thomas A., Mousavi M., Kaiser G., Köttstorfer J., Kecht M., et al. Elevated transforming growth factor-beta 1 (TGF-β1) levels in human fracture healing. Injury 2011, 42:833-837.
56. Scott M.A., Levi B., Askarinam A., Nguyen A., Rackohn T., Ting K., et al. Brief review of models of ectopic bone formation. Stem Cells Dev. 2011, 21:655-667.
57. Levi B., James A.W., Nelson E.R., Peng M., Wan D.C., Commons G.W., et al. Acute skeletal injury is necessary for human adipose-derived stromal cell mediated calvarial regeneration. Plastic Reconstr. Surg. 2011, 127:1118.
58. Kuroda S., Wazen R., Moffatt P., Tanaka E., Nanci A. Mechanical stress induces bone formation in the maxillary sinus in a short-term mouse model. Clin. oral Investig. 2013, 17:131-137.
59. Allori A.C., Sailon A.M., Pan J.H., Warren S.M. Biological basis of bone formation, remodeling, and repair-part III: biomechanical forces. Tissue Eng. Part B: Rev. 2008, 14:285-293.
60. Bahar H., Yaffe A., Boskey A., Binderman I. Influence of bone-derived matrices on generation of bone in an ectopic rat model. J. Orthop. Res. 2010, 28:664-670.
61. Ma D., Yao H., Tian W., Chen F., Liu Y., Mao T., et al. Enhancing bone formation by transplantation of a scaffold-free tissue-engineered periosteum in a rabbit model. Clin. Oral Implants Res. 2011, 22:1193-1199.
62. Matsushima A., Kotobuki N., Tadokoro M., Kawate K., Yajima H., Takakura Y., et al. Vivo osteogenic capability of human mesenchymal cells cultured on hydroxyapatite and on β-tricalcium phosphate. Artif. Organs 2009, 33:474-481.
63. Kinard L.A., Dahlin R.L., Lam J., Lu S., Lee E.J., Kasper F.K., et al. Synthetic biodegradable hydrogel delivery of demineralized bone matrix for bone augmentation in a rat model. Acta Biomater. 2014, 10:4574-4582.
64. Pearce A., Richards R., Milz S., Schneider E., Pearce S. Animal models for implant biomaterial research in bone: a review. Eur. Cell. Mater. 2007, 13:1-10.